Subtle cues prompt cell signals

If you thought that all it took to kick-start a signaling pathway was a ligand binding to a receptor, think again. How and when that binding occurs, it turns out, is what determines what happens inside the cell. In linkurl:a study;http://www.cell.com/content/article/fulltext?uid=PIIS0092867408000470 published online in Cell today, Sherry LaPorte of Stanford University and colleagues describe the structure of the Interleukin-4 and Interleukin-13 (IL-4/13) cytokines and the complete set of receptors they bind, including the one receptor complex they have in common. It's not very surprising that different ligands can act on the same receptor to trigger different signal cascades. But the authors' crystal structures reveal that identical receptors can distinguish between ligands that differ only slightly, such as the IL4 and IL-13 molecules. The receptor that IL-4 and IL-13 share is actually a composite of two receptors: the IL-14 receptor α and the IL-13 receptor α. Both are required to initiate a signal, but the IL-4 touches the IL-4 receptor first and with higher affinity, while IL-13 touches the IL-13 receptor first. The researchers think it's this slight difference in the order of contact and affinity that triggers one signaling pathway versus another. Most ligands work by bringing receptors components together at the cell surface. For many receptors, that is sufficient for initiating a signal. This study shows that kick-starting a signaling pathway depends not just on activating the receptor, but also on the intricate differences in movement and binding on the extracellular face of the receptor, writes Alexander Wlodawer from the National Cancer Institute in a linkurl:commentary;http://www.cell.com/content/article/fulltext?uid=PIIS0092867408000615 accompanying the article. Wlodawer, who was not involved in this research, told The Scientist that the study has important implications for linkurl:drug design,;http://www.the-scientist.com/article/display/15706/ since IL-4 and IL-13 initiate specific signaling pathways that are both important in allergy and asthma. Understanding the specific sequence of events that triggers one signal versus another will help drug makers design molecules that mimic that behavior. But, he added, researchers don't yet have the full picture of how molecules at the cell surface interact to determine the specificity and strength of the signal propagated within the cell.

Subtle cues prompt cell signals

The Scientist ARCHIVES

Become a Member of

Meet the Author

Edyta Zielinska

Related Research Resources

Study Confirms Safety of Genetically Modified T Cells

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Making Real-Time PCR More Straightforward

Characterizing Immune Memory to COVID-19 Vaccination

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Products

Product News

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

Agilent BioTek Cytation C10 Confocal Imaging Reader